Effect of Shockwave Therapy on Low Back Pain in Primary Dysmenorrhea
1 other identifier
interventional
60
1 country
1
Brief Summary
Primary dysmenorrhea (PD), defined as menstrual pain without any structural lesions, usually begins shortly before or immediately after the onset of the menstrual cycle and commonly lasts for 48 to 72 hour
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2024
CompletedFirst Submitted
Initial submission to the registry
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 7, 2025
CompletedJanuary 7, 2025
January 1, 2025
6 months
December 30, 2024
January 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain assessment
VAS scoring method. 0 is the least while 10 is the highest
every month for three menstrual cycle
Study Arms (2)
Hot back group
ACTIVE COMPARATOR30 subjects were treated by hot back in the first 3 days of the menstrual cycle (follicular phase) for three consecutive menstrual cycles
shock wave and hot back group
EXPERIMENTAL30 subjects were treated by hot back and shockwave therapy in the first 3 days of the menstrual cycle (follicular phase) for three consecutive menstrual cycles
Interventions
Eligibility Criteria
You may qualify if:
- Their ages ranged from 18 to 30 years.
- Their BMI were not exceeding 29 Kg/m2.
- All patients were clinically diagnosed as low back pain during Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guideline
You may not qualify if:
- Any known chronic disease (such as cardiovascular or renal diseases) or secondary dysmenorrhea.
- Being pregnant or planning to get pregnant any time during the trial.
- Having received other treatments for PD in the past half year.
- Irregular menstrual cycles.
- Mental or neurological disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Deraya Universitylead
- Cairo Universitycollaborator
Study Sites (1)
Minia
Minya, 05637, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 30, 2024
First Posted
January 7, 2025
Study Start
September 10, 2023
Primary Completion
March 2, 2024
Study Completion
January 1, 2025
Last Updated
January 7, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share